- BNY to Add Staking for Institutional Clients to Digital Asset Custody Platform
- Ethereum researchers want to burn staking rewards gradually
- SHOPIFY INC. <SHOP.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $185 FROM $175
- Winshear Metals extends high-grade nickel-copper-cobalt mineralization at Portsoy project in Scotland
- Nayax files Connecticut application for US innovation bank charter
- PepGen advances PGN-EDODM1 into 12.5 mg/kg cohort in Phase 2 FREEDOM2-DM1 trial
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. <CRL.N>: JEFFERIES RAISES TARGET PRICE TO $305 FROM $225
- Installed Building Products FY26 Q2 net income drops 5.94% to $64.9 million; revenue rises 2.3% to $777.8 million
- Parker Hannifin FY26 Q4 adjusted EPS climbs 21% to $9.27; net sales rise 10% to $5.76 billion
- PAYCOM SOFTWARE, INC. : DEUTSCHE BANK RAISES TARGET PRICE TO $205 FROM $140
- Kelly Q2 FY26 net earnings drop 40% to $11.4 million; revenue falls 5.8% to $1.04 billion
- NetScout FY27 Q1 GAAP net income turns to USD 21.8 million; revenue rises 12.7% to USD 210.4 million
- APPLOVIN CORPORATION : RAYMOND JAMES CUTS TARGET PRICE TO $590 FROM $640
- Sunstone Hotel Investors Q2 FY26 net income attributable to common stockholders more than doubled to $26 million; RevPAR rises 9.3% to $263.61
- MACOM FY26 Q3 GAAP net income more than doubled to $100.71 million; revenue rises 35.8% to $342.2 million
- PepGen Q2 FY26 net loss narrows 22.84% to $17.81 million
- ZIMMER BIOMET HOLDINGS, INC. <ZBH.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $98 FROM $88
- BRIEF-PepGen Q2 EPS USD -0.26
- Payoneer Q2 FY26 turns to net loss of USD 2.44 million; revenue rises 5% to USD 274.3 million
- Sunrise Realty Trust Q2 FY26 net income falls 8.41% to $3.08 million; interest income rises 26.8% to $8.56 million
- BCM Resources drills 550-meter porphyry-skarn mineralized interval at Utah Thompson Knolls project
- ATI Q2 2026 adjusted EBITDA climbs 37% y/y to $284 million; revenue rises 11% y/y to $1.3 billion
- Priority Technology Q2 net income falls 9.3% to $9.9 million; revenue rises 9.4% to $262.3 million
- Orion Digital Q2 FY26 swings to net loss of CAD 744,000; revenue slips 0.46% to CAD 16.86 million
- Arianne Phosphate’s Lac à Paul project joins Quebec government’s Filon fast-track support program
- Evolent Health Q2 revenue beats expectations
- Compass Therapeutics Q2 2026 net loss widens 26.63% to $25.2 million; R&D expenses rise 19% to $19.6 million
- The Financial Times reported, citing sources, that if the inflation data released in the coming weeks proves strong and market expectations for higher borrowing costs intensify, Federal Reserve Chair Waller will be prepared to raise interest rates at the September meeting.
- Natural gas is hard to exit from the US power system: domestic resources, pipeline networks, and flexibility form a triple moat
- The wave of resistance against AI data centers spreads to India, as Google (GOOGL.US) faces an environmental crisis with its $15-billion project
- FrontView REIT Q2 adjusted FFO per share rises
- CME Group declares Q3 dividend of $1.3 a share
- Genie Energy 2Q26 net income more than quadruples to $11.4 million; revenue falls 4.7% to $100.4 million
- Abeona Therapeutics schedules conference call on Q2 2026 results
- BRIEF-Lexicon Pharmaceuticals Q2 EPS USD -0.07
- BRIEF-Cronos Group Q2 Gross Profit USD 28.5 Million
- BRIEF-Kelly Services Q2 Adjusted EPS USD 0.37
- BRIEF-Nuvation Bio Q2 EPS USD -0.18
- NetScout Systems 1Q Adj EPS 52c >NTCT
- Sunstone Hotel Investors 2Q Rev $277.1M >SHO
- Sunstone Hotel Investors 2Q EPS 14c >SHO
- Installed Building 2Q Rev $777.8M >IBP
- Installed Building 2Q Adj EPS $2.91 >IBP
- Installed Building 2Q EPS $2.43 >IBP
- Priority Tech Holdings 2Q Rev $262.3M >PRTH
- Priority Tech Holdings 2Q EPS 12c >PRTH
- Parker-Hannifin 4Q Sales $5.8B >PH
- Parker-Hannifin 4Q Net $1.09B >PH
- Parker-Hannifin 4Q Adj EPS $9.27 >PH
- Parker-Hannifin Sees FY EPS $30.00-EPS $31.00 >PH
- Parker-Hannifin 4Q EPS $8.54 >PH
- Parker-Hannifin Sees FY Adj EPS $34.25-Adj EPS $35.25 >PH
- NetScout Systems 1Q Rev $210.4M >NTCT
- Lexicon Pharma 2Q Rev $692,000 >LXRX
- Lexicon Pharma 2Q Loss $31.8M >LXRX
- ITT Inc 2Q Net $84.9M >ITT
- ITT Inc Sees FY Cont Ops EPS $4.47-EPS $4.67 >ITT
- ITT Inc Sees FY Adj EPS $8.12-Adj EPS $8.32 >ITT
- Collegium Pharmaceutical 2Q Loss/Shr 46c >COLL
- CHOICE HOTELS INTERNATIONAL, INC. <CHH.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $124 FROM $116
- HUBSPOT, INC. <HUBS.N>: STIFEL CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $200 FROM $275
- LYELL IMMUNOPHARMA, INC. <LYEL.O>: STIFEL INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $36
- GH Research says H1 loss widens as R&D spending rises on GH001 clinical, technical development work
- Cogent Q2 FY26 net income turns to profit at USD 66.64 million; revenue falls 1.5% to USD 235.56 million vs Q1 FY26
- Avalo Therapeutics posts corporate deck spotlighting IL-1β inhibitor pipeline for hidradenitis suppurativa
- Safe Pro Group receives USD 780,000 Department of War prime contractor purchase order
- Keurig Dr Pepper Q2 FY26 GAAP diluted EPS drops 90% to $0.04; net sales rise 75.6% to $7.31 billion
- MEDLINE INC. <MDLN.O>: STIFEL CUTS TARGET PRICE TO $45 FROM $50
- UACJ raises FY2026 operating profit forecast to ¥85 billion
- LCI INDUSTRIES <LCII.N>: STIFEL CUTS TARGET PRICE TO $130 FROM $137
- Banca Sistema 1H26 net income drops 69% y/y to €4.5 million
- PAYCOM SOFTWARE, INC. : STIFEL RAISES TARGET PRICE TO $200 FROM $120
- Mobix Labs announces investor strategic update call
- KRATOS DEFENSE & SECURITY SOLUTIONS, INC. <KTOS.O>: STIFEL CUTS TARGET PRICE TO $115 FROM $134
- POWER INTEGRATIONS, INC. : STIFEL CUTS TARGET PRICE TO $80 FROM $95
- INSULET CORPORATION : STIFEL CUTS TARGET PRICE TO $180 FROM $225
- SOLVENTUM CORPORATION <SOLV.N>: STIFEL RAISES TARGET PRICE TO $100 FROM $90
- Monte Rosa publishes corporate presentation on targeted protein degradation pipeline and molecular glue degraders
- D-Wave Q2 FY26 net loss narrows 71.31% to $48 million; revenue flat at $3.1 million
- FRESHPET, INC. <FRPT.O>: STIFEL RAISES TARGET PRICE TO $78 FROM $66
- Amundi trims Munich Re voting rights to 2.97% from 3.16%
- Siili Solutions cuts 2026 revenue outlook to EUR 95-105 million
- Silver Storm drills 215 g/t silver equivalent over 11.9 m at La Parrilla Rosarios Zone in Mexico
- ATS Q1 FY2027 adjusted revenue falls 5.2% on project timing, lower GLP-1-related demand, transportation restructuring impacts, company says
- White Pearl Technology, Aixia CEOs to host Q&A on takeover offer Friday
- Precision BioSciences Q2 net loss widens to $32.65 million; revenue drops to no revenue
- BKV posts investor presentation on website
- Camino Minerals launches brokered private placement of up to C$5.04 million units at C$0.42 each
- Immunovant FY27 Q1 net loss widens 27% to $153.2 million; R&D expenses rise 40.9% to $142.6 million
- Driven Brands Q2 FY26 net income from continuing operations more than doubled to $37.3 million; revenue rises 6.8% to $507.4 million
- WASGAU turns to H1 FY26 net loss of EUR 735,000; revenue rises 1.39% to EUR 325.3 million
- CURALEAF HOLDINGS, INC. <CURA.TO>: ALLIANCE GLOBAL PARTNERS ADJUSTS TARGET PRICE TO C$21 FROM C$6.5 TO REFLECT 1-FOR-3 REVERSE STOCK SPLIT
- Gogo 2Q Rev $222.8M >GOGO
- Viatris 2Q Loss/Shr 10c >VTRS
- Aclaris Therapeutics 2Q Loss/Shr 15c >ACRS
- Aclaris Therapeutics 2Q Loss $21.5M >ACRS
- Core Natural Resources 2Q EPS $2.51 >CNR
- Bob's Discount Furniture 2Q Rev $619.6M >BOBS
- Lincoln International 2Q Loss $23M >LCLN
- Lincoln International 2Q EPS 1c >LCLN
